XML 171 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2019
Operating activities:      
Net income $ 9,106,000 $ 59,672,000 $ 42,577,000
Adjustments to reconcile net income to net cash provided by (used for) operating activities:      
Depreciation and amortization 28,153,000 29,126,000 32,675,000
Deferred income taxes and related valuation allowance (8,704,000) 7,364,000 (958,000)
Net loss (gain) on sale of real estate, investments and other (1,594,000) (563,000) 194,000
Loss on sales of businesses 0 176,000 25,672,000
Pension Expense (Reversal of Expense), Noncash 19,038,000 0 0
Gain (Loss) on Disposition of Property Plant Equipment (2,638,000) 0 0
Amortization of deferred financing costs 2,646,000 2,655,000 2,655,000
Stock-based compensation 8,022,000 4,507,000 6,198,000
Other Operating Activities, Cash Flow Statement 7,447,000 7,923,000 0
Changes in operating assets and liabilities, net of effects of business acquisitions and divestitures:      
Trade accounts receivable 21,472,000 2,899,000 (11,328,000)
Inventories 20,659,000 15,752,000 (15,411,000)
Prepaid expenses and other (5,128,000) (3,857,000) (128,000)
Increase (Decrease) in Other Operating Assets (874,000) (724,000) (231,000)
Trade accounts payable 10,343,000 8,110,000 3,881,000
Accrued liabilities (3,174,000) (14,304,000) 6,397,000
Increase (Decrease) in Other Noncurrent Liabilities (7,632,000) (13,389,000) (13,156,000)
Net cash provided by (used for) operating activities 98,890,000 106,795,000 79,499,000
Investing activities:      
Proceeds from sales of marketable securities 5,111,000 5,380,000 3,266,000
Purchases of marketable securities (4,945,000) (5,747,000) (2,604,000)
Capital expenditures (12,300,000) (9,432,000) (12,288,000)
Proceeds from Sales of Assets, Investing Activities 5,453,000 0 0
Proceeds from Insurance Settlement, Investing Activities (100,000) 0 0
Proceeds from Equity Method Investment, Distribution, Return of Capital (587,000) 0 0
Proceeds from Sale of Property, Plant, and Equipment 446,000 51,000 176,000
Payments for (Proceeds from) Businesses and Interest in Affiliates 0    
Proceeds from Divestiture of Businesses   (214,000) 14,230,000
Net Cash Provided by (Used in) Investing Activities (5,548,000) (9,962,000) 2,486,000
Financing activities:      
Proceeds from issuance of common stock 1,973,000 6,000,000 4,152,000
Proceeds from (Repayments of) Debt, Maturing in More than Three Months 25,000,000 0 0
Repayments of Lines of Credit (25,000,000) 0 0
Payments of Dividends (5,733,000) (5,670,000) (4,652,000)
Repayment of debt (4,450,000) (51,113,000) (65,088,000)
Payments of Financing Costs 826,000 0 0
Other (1,153,000) (768,000) (2,190,000)
Net cash provided by (used for) financing activities (10,189,000) (51,551,000) (67,778,000)
Effect of exchange rate changes on cash 4,524,000 (1,925,000) (6,429,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 87,677,000 43,357,000 7,778,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 202,377,000 114,700,000 71,343,000
Supplementary cash flows data:      
Interest Paid, Excluding Capitalized Interest, Operating Activities 9,451,000 11,555,000 14,411,000
Income taxes paid, net of refunds 10,186,000 11,601,000 4,840,000
Property, plant and equipment purchases included in trade accounts payable 730,000 365,000 227,000
Decrease in Restricted Cash 250,000 250,000 250,000
Payments to Acquire Restricted Investments $ 0 $ 0 $ (294,000)